pathway,nums,percent,pvalue
Adherens junction,93,0.5376344086021505,0.0
Adipocytokine signaling pathway,73,0.3698630136986301,0.0
Antigen processing and presentation,97,0.27835051546391754,0.0
Axon guidance,183,0.2786885245901639,0.0
B cell receptor signaling pathway,85,0.43529411764705883,0.0
Basal transcription factors,45,0.35555555555555557,0.0
Base excision repair,49,0.8367346938775511,0.0
BRCA1-associated genome surveillance complex (BASC),16,1.0625,0.0
Cell adhesion molecules (CAMs),169,0.28994082840236685,0.0
Cell cycle,157,0.8089171974522293,0.0
Cell cycle - G2/M transition,10,0.9,0.0
Chagas disease (American trypanosomiasis),101,0.5544554455445545,0.0
Chemokine signaling pathway,204,0.4803921568627451,0.0
Cholinergic synapse,114,0.3508771929824561,0.0
Cytokine-cytokine receptor interaction,326,0.3282208588957055,0.0
Cytosolic DNA-sensing pathway,80,0.475,0.0
DNA replication,35,1.3428571428571427,0.0
Drug metabolism - other enzymes,92,0.41304347826086957,0.0
Endocytosis,297,0.4208754208754209,0.0
Exon junction complex (EJC),22,1.2272727272727273,0.0
Fc epsilon RI signaling pathway,68,0.36764705882352944,0.0
Fc gamma R-mediated phagocytosis,97,0.6597938144329897,0.0
Focal adhesion,204,0.6274509803921569,0.0
GnRH signaling pathway,90,0.4777777777777778,0.0
Hematopoietic cell lineage,98,0.2653061224489796,0.0
Homologous recombination,42,0.4523809523809524,0.0
Huntington's disease,194,0.5824742268041238,0.0
IL-17 signaling pathway,93,0.3548387096774194,0.0
Inflammatory bowel disease (IBD),59,0.5254237288135594,0.0
Inositol phosphate metabolism,73,0.3150684931506849,0.0
Intestinal immune network for IgA production,45,0.35555555555555557,0.0
JAK-STAT signaling,19,0.7368421052631579,0.0
Jak-STAT signaling pathway,159,0.4025157232704403,0.0
Leukocyte transendothelial migration,121,0.5785123966942148,0.0
Lysine degradation,67,0.47761194029850745,0.0
MCM complex,6,2.1666666666666665,0.0
Mismatch repair,22,1.4090909090909092,0.0
mRNA surveillance pathway,105,0.638095238095238,0.0
Natural killer cell mediated cytotoxicity,123,0.4065040650406504,0.0
NF-kappa B signaling pathway,114,0.5350877192982456,0.0
NOD-like receptor signaling pathway,220,0.5227272727272727,0.0
Nuclear pore complex,41,0.9512195121951219,0.0
Nucleotide excision repair,58,1.0344827586206897,0.0
Oocyte meiosis,123,0.7073170731707317,0.0
Osteoclast differentiation,140,0.5142857142857142,0.0
Oxidative phosphorylation,151,0.32450331125827814,0.0
Phagosome,192,0.4583333333333333,0.0
Phospholipase D signaling pathway,150,0.3933333333333333,0.0
Platelet activation,126,0.6111111111111112,0.0
Progesterone-mediated oocyte maturation,92,0.8043478260869565,0.0
Prolactin signaling pathway,74,0.22972972972972974,0.0
Pyrimidine metabolism,107,0.6728971962616822,0.0
Rap1 signaling pathway,218,0.5137614678899083,0.0
Regulation of actin cytoskeleton,239,0.5523012552301255,0.0
Ribosome,187,0.47058823529411764,0.0
Ribosome biogenesis in eukaryotes,125,0.52,0.0
"Ribosome, eukaryotes",98,0.6326530612244898,0.0
RIG-I-like receptor signaling pathway,73,0.3972602739726027,0.0
RNA degradation,90,0.3111111111111111,0.0
RNA transport,167,0.8263473053892215,0.0
Sphingolipid signaling pathway,127,0.44881889763779526,0.0
Spliceosome,186,0.6774193548387096,0.0
"Spliceosome, 35S U5-snRNP",36,0.9722222222222222,0.0
"Spliceosome, U1-snRNP",11,1.3636363636363635,0.0
"Spliceosome, U2-snRNP",21,1.7619047619047619,0.0
"Spliceosome, U4/U6.U5 tri-snRNP",32,1.09375,0.0
Th1 and Th2 cell differentiation,89,0.4044943820224719,0.0
Th17 cell differentiation,107,0.5607476635514018,0.0
TNF signaling pathway,115,0.5043478260869565,0.0
Toll-like receptor signaling pathway,104,0.5192307692307693,0.0
Nucleotide metabolism,84,0.5357142857142857,0.0
Biosynthesis of cofactors,152,0.26973684210526316,0.0
Nucleocytoplasmic transport,117,0.8547008547008547,0.0
ATP-dependent chromatin remodeling,136,0.4264705882352941,0.0
Polycomb repressive complex,84,0.5833333333333334,0.0
JAK-STAT signaling pathway,171,0.3742690058479532,0.0
Viral protein interaction with cytokine and cytokine receptor,95,0.3157894736842105,0.0
Cell adhesion molecules,182,0.2692307692307692,0.0
Motor proteins,196,0.5408163265306123,0.0
Neutrophil extracellular trap formation,208,0.3173076923076923,0.0
C-type lectin receptor signaling pathway,112,0.5267857142857143,0.0
Relaxin signaling pathway,129,0.4728682170542636,0.0
"Growth hormone synthesis, secretion and action",117,0.3333333333333333,0.0
"Parathyroid hormone synthesis, secretion and action",108,0.39814814814814814,0.0
Thermogenesis,231,0.46320346320346323,0.0
Pathways in cancer,543,0.5340699815837937,0.0
Proteoglycans in cancer,205,0.5853658536585366,0.0
Choline metabolism in cancer,98,0.29591836734693877,0.0
PD-L1 expression and PD-1 checkpoint pathway in cancer,88,0.4431818181818182,0.0
Renal cell carcinoma,68,0.3235294117647059,0.0
Human immunodeficiency virus 1 infection,239,0.5857740585774058,0.0
Measles,145,0.5379310344827586,0.0
Herpes simplex virus 1 infection,458,0.2838427947598253,0.0
Human cytomegalovirus infection,255,0.6313725490196078,0.0
Kaposi sarcoma-associated herpesvirus infection,223,0.5739910313901345,0.0
Epstein-Barr virus infection,230,0.6739130434782609,0.0
Yersinia infection,135,0.6222222222222222,0.0
Staphylococcus aureus infection,128,0.171875,0.0
Tuberculosis,180,0.5388888888888889,0.0
Bacterial invasion of epithelial cells,76,0.631578947368421,0.0
Amoebiasis,107,0.5514018691588785,0.0
Malaria,57,0.3684210526315789,0.0
Toxoplasmosis,109,0.7247706422018348,0.0
Leishmaniasis,70,0.45714285714285713,0.0
Chagas disease,103,0.4563106796116505,0.0
Rheumatoid arthritis,87,0.5287356321839081,0.0
Autoimmune thyroid disease,78,0.19230769230769232,0.0
Inflammatory bowel disease,62,0.5161290322580645,0.0
Allograft rejection,62,0.24193548387096775,0.0
Graft-versus-host disease,62,0.1935483870967742,0.0
Primary immunodeficiency,36,0.25,0.0
Alzheimer disease,383,0.4699738903394256,0.0
Parkinson disease,264,0.5643939393939394,0.0
Amyotrophic lateral sclerosis,369,0.5880758807588076,0.0
Huntington disease,302,0.5364238410596026,0.0
Prion disease,267,0.5805243445692884,0.0
Lipid and atherosclerosis,216,0.5416666666666666,0.0
Viral myocarditis,87,0.3793103448275862,0.0
Type I diabetes mellitus,69,0.2608695652173913,0.0
Alcoholic liver disease,141,0.48936170212765956,0.0
AGE-RAGE signaling pathway in diabetic complications,101,0.801980198019802,0.0
Cysteine and methionine metabolism,57,0.21052631578947367,0.001
ECM-receptor interaction,89,0.4044943820224719,0.001
Fatty acid elongation,29,0.10344827586206896,0.001
Long-term depression,61,0.18032786885245902,0.001
MAPK signaling pathway,252,0.46825396825396826,0.001
Ras signaling pathway,242,0.36363636363636365,0.001
Sm core complex,8,1.375,0.001
T cell receptor signaling pathway,125,0.44,0.001
TGF-beta signaling,8,0.375,0.001
mmuK signaling pathway,301,0.46511627906976744,0.001
Cortisol synthesis and secretion,72,0.3055555555555556,0.001
Influenza A,173,0.6011560693641619,0.001
Salmonella infection,253,0.6442687747035574,0.001
Legionellosis,60,0.43333333333333335,0.001
Spinocerebellar ataxia,141,0.45390070921985815,0.001
Apelin signaling pathway,145,0.5241379310344828,0.002
Biosynthesis of unsaturated fatty acids,36,0.16666666666666666,0.002
Cardiac muscle contraction,87,0.47126436781609193,0.002
"Citrate cycle (TCA cycle, Krebs cycle)",24,0.16666666666666666,0.002
Purine metabolism,185,0.4864864864864865,0.002
Toll-like receptor signaling,15,0.2,0.002
Hepatitis B,163,0.7668711656441718,0.002
"Fatty acid biosynthesis, elongation, endoplasmic reticulum",13,0.23076923076923078,0.003
Glutathione metabolism,74,0.2972972972972973,0.003
Herpes simplex infection,215,0.6139534883720931,0.003
Lysosome,136,0.25735294117647056,0.003
Transcriptional misregulation in cancer,224,0.39285714285714285,0.003
Type II diabetes mellitus,48,0.1875,0.003
ErbB signaling pathway,86,0.29069767441860467,0.004
Notch signaling pathway,63,0.25396825396825395,0.004
One carbon pool by folate,19,0.3157894736842105,0.004
Parkinson's disease,144,0.5277777777777778,0.004
Fluid shear stress and atherosclerosis,147,0.6326530612244898,0.004
H/ACA ribonucleoprotein complex,4,1.25,0.005
Coronavirus disease - COVID-19,249,0.606425702811245,0.006
Cytochrome bc1 complex,10,0.3,0.007
Aldosterone-regulated sodium reabsorption,39,0.38461538461538464,0.008
Cell cycle - G1/S transition,13,0.6153846153846154,0.008
APC/C complex,14,0.21428571428571427,0.009
Neuroactive ligand-receptor interaction,393,0.05343511450381679,0.009
Nicotinate and nicotinamide metabolism,45,0.13333333333333333,0.009
"Proteasome, 19S regulatory particle (PA700)",19,0.5263157894736842,0.009
RNA polymerase,36,0.5277777777777778,0.009
Necroptosis,175,0.5542857142857143,0.009
Melanoma,72,0.5416666666666666,0.009
RF-C complex,5,1.4,0.01
Alzheimer's disease,175,0.4857142857142857,0.012
Amino sugar and nucleotide sugar metabolism,52,0.1346153846153846,0.012
"F-type ATPase, eukaryotes",17,0.23529411764705882,0.012
ABC transporters,52,0.1346153846153846,0.013
"Guanine ribonucleotide biosynthesis IMP => GDP,GTP",12,0.5833333333333334,0.013
Lsm 2-8 complex,7,0.7142857142857143,0.014
Amphetamine addiction,69,0.391304347826087,0.015
Apoptosis,137,0.6934306569343066,0.016
Estrogen signaling pathway,134,0.34328358208955223,0.016
Biosynthesis of nucleotide sugars,38,0.18421052631578946,0.017
Alcoholism,205,0.2048780487804878,0.017
GINS complex,4,1.0,0.02
p53 signaling pathway,74,0.7972972972972973,0.02
Glioma,74,0.6216216216216216,0.02
Glycerophospholipid metabolism,99,0.030303030303030304,0.023
TREX complex,10,0.4,0.023
Pathways of neurodegeneration - multiple diseases,471,0.4968152866242038,0.023
Complement and coagulation cascades,94,0.19148936170212766,0.025
"Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate",14,0.21428571428571427,0.026
Arginine and proline metabolism,57,0.14035087719298245,0.028
Hepatocellular carcinoma,174,0.5459770114942529,0.029
Pertussis,77,0.4025974025974026,0.029
"Valine, leucine and isoleucine degradation",57,0.2982456140350877,0.033
Prion diseases,34,0.17647058823529413,0.034
Insulin resistance,110,0.5545454545454546,0.037
Aminoacyl-tRNA biosynthesis,84,0.07142857142857142,0.038
Vasopressin-regulated water reabsorption,44,0.29545454545454547,0.038
Carbohydrate digestion and absorption,49,0.1836734693877551,0.039
Synaptic vesicle cycle,77,0.05194805194805195,0.039
"Aminoacyl-tRNA biosynthesis, eukaryotes",38,0.18421052631578946,0.04
Methionine degradation,11,0.2727272727272727,0.04
"RNA polymerase I, eukaryotes",13,0.38461538461538464,0.041
DNA polymerase alpha / primase complex,4,1.0,0.042
Ubiquitin mediated proteolysis,151,0.5496688741721855,0.043
Glutamatergic synapse,116,0.20689655172413793,0.045
Immunoproteasome,18,0.6666666666666666,0.046
Phosphatidylinositol signaling system,99,0.21212121212121213,0.047
VEGF signaling pathway,58,0.3103448275862069,0.047
Hepatitis C,166,0.6385542168674698,0.047
Lsm 1-7 complex,7,0.5714285714285714,0.048
Systemic lupus erythematosus,149,0.08053691275167785,0.054
Hippo signaling pathway - multiple species,27,0.2222222222222222,0.055
Neurotrophin signaling pathway,121,0.4049586776859504,0.057
cAMP signaling pathway,224,0.3392857142857143,0.069
Hippo signaling pathway -multiple species,26,0.23076923076923078,0.069
Longevity regulating pathway - multiple species,62,0.3870967741935484,0.07
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex,16,0.3125,0.072
Thyroid hormone synthesis,74,0.33783783783783783,0.072
Protein digestion and absorption,110,0.21818181818181817,0.074
DNA damage-induced cell cycle checkpoints,7,0.42857142857142855,0.075
Metabolic pathways,1315,0.3855513307984791,0.076
Dopaminergic synapse,138,0.36231884057971014,0.082
Bladder cancer,41,0.6585365853658537,0.083
Fanconi anemia pathway,51,0.058823529411764705,0.084
Longevity regulating pathway,90,0.37777777777777777,0.084
Cushing syndrome,162,0.4506172839506173,0.085
Glucagon signaling pathway,108,0.32407407407407407,0.086
PPAR signaling pathway,90,0.36666666666666664,0.096
Cytochrome c oxidase,25,0.36,0.097
"Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate",10,0.3,0.098
Breast cancer,147,0.47619047619047616,0.103
Gastric cancer,150,0.4533333333333333,0.104
Circadian entrainment,100,0.23,0.106
Insulin secretion,86,0.23255813953488372,0.106
Holo-TFIIH complex,10,0.3,0.107
PI3K-Akt signaling pathway,373,0.4691689008042895,0.109
Viral life cycle - HIV-1,61,0.8032786885245902,0.109
Fatty acid metabolism,64,0.296875,0.113
Chronic myeloid leukemia,76,0.6973684210526315,0.114
Glycosphingolipid biosynthesis - globo and isoglobo series,17,0.17647058823529413,0.117
Tight junction,179,0.5418994413407822,0.12
Central carbon metabolism in cancer,69,0.08695652173913043,0.12
Ovarian steroidogenesis,65,0.1076923076923077,0.123
Renin secretion,76,0.14473684210526316,0.127
Efferocytosis,155,0.4258064516129032,0.13
HIF-1 signaling pathway,120,0.325,0.132
N-Glycan biosynthesis,53,0.05660377358490566,0.132
Salivary secretion,88,0.23863636363636365,0.132
Hypertrophic cardiomyopathy (HCM),84,0.47619047619047616,0.139
Human papillomavirus infection,361,0.48753462603878117,0.14
Glycosphingolipid biosynthesis - lacto and neolacto series,28,0.10714285714285714,0.146
"RNA polymerase III, eukaryotes",18,0.3333333333333333,0.146
Thyroid cancer,37,0.08108108108108109,0.147
Melanogenesis,100,0.3,0.151
Peroxisome,87,0.3563218390804598,0.153
Hedgehog signaling pathway,58,0.05172413793103448,0.154
Oxytocin signaling pathway,154,0.44155844155844154,0.154
Protein processing in endoplasmic reticulum,183,0.3825136612021858,0.159
BER complex,10,0.4,0.162
"Proteasome, 20S core particle",15,0.2,0.165
Asthma,25,0.12,0.165
Vascular smooth muscle contraction,145,0.3724137931034483,0.168
Chemical carcinogenesis - receptor activation,225,0.4533333333333333,0.178
Proteasome,47,0.7021276595744681,0.185
Autophagy - animal,167,0.2994011976047904,0.189
Protein export,31,0.22580645161290322,0.19
Adrenergic signaling in cardiomyocytes,156,0.5256410256410257,0.192
"RNA polymerase II, eukaryotes",13,0.46153846153846156,0.196
Retrograde endocannabinoid signaling,150,0.32,0.209
Glyoxylate and dicarboxylate metabolism,32,0.21875,0.215
Long-term potentiation,67,0.3283582089552239,0.22
Cul4-DDB1-DDB2 complex,6,0.5,0.228
SNARE interactions in vesicular transport,33,0.21212121212121213,0.23
Dilated cardiomyopathy,94,0.48936170212765956,0.231
NADH dehydrogenase (ubiquinone) 1 beta subcomplex,14,0.21428571428571427,0.232
cAMP signaling,15,0.26666666666666666,0.242
Drug metabolism - cytochrome P450,72,0.09722222222222222,0.251
mTOR signaling pathway,158,0.27848101265822783,0.264
GnRH secretion,63,0.23809523809523808,0.279
AMPK signaling pathway,128,0.4140625,0.288
Thyroid hormone signaling pathway,120,0.5583333333333333,0.289
Inflammatory mediator regulation of TRP channels,127,0.31496062992125984,0.293
Riboflavin metabolism,8,0.375,0.301
Cocaine addiction,48,0.20833333333333334,0.306
"Lysine degradation, lysine => saccharopine => acetoacetyl-CoA",11,0.36363636363636365,0.312
Lipoic acid metabolism,19,0.3684210526315789,0.314
Small cell lung cancer,93,0.9139784946236559,0.314
"V-type ATPase, eukaryotes",24,0.125,0.315
Platinum drug resistance,80,0.65,0.322
Succinate dehydrogenase (ubiquinone),4,0.75,0.332
Metabolism of xenobiotics by cytochrome P450,75,0.13333333333333333,0.34
Renin-angiotensin system,37,0.08108108108108109,0.345
Tryptophan metabolism,54,0.2222222222222222,0.345
Viral carcinogenesis,228,0.6096491228070176,0.345
Hypertrophic cardiomyopathy,91,0.4725274725274725,0.354
MAPK (p38) signaling,22,0.13636363636363635,0.379
Non-small cell lung cancer,72,0.6805555555555556,0.38
Amyotrophic lateral sclerosis (ALS),52,0.19230769230769232,0.381
Ferroptosis,42,0.07142857142857142,0.391
Sulfur relay system,8,0.375,0.392
Basal cell carcinoma,63,0.047619047619047616,0.392
Citrate cycle (TCA cycle),32,0.3125,0.418
Prostate cancer,99,0.47474747474747475,0.429
2-Oxocarboxylic acid metabolism,34,0.29411764705882354,0.445
Fatty acid degradation,53,0.18867924528301888,0.445
GABAergic synapse,91,0.10989010989010989,0.453
EGFR tyrosine kinase inhibitor resistance,79,0.35443037974683544,0.457
TGF-beta signaling pathway,112,0.5178571428571429,0.461
Endometrial cancer,58,0.10344827586206896,0.472
Morphine addiction,91,0.24175824175824176,0.499
Hippo signaling pathway,158,0.4620253164556962,0.514
Thiamine metabolism,15,0.2,0.514
Apoptosis - multiple species,33,0.45454545454545453,0.516
Cholesterol metabolism,50,0.2,0.543
"Pyruvate oxidation, pyruvate => acetyl-CoA",5,0.6,0.557
Gastric acid secretion,75,0.22666666666666666,0.575
Carbon metabolism,126,0.4444444444444444,0.582
Serotonergic synapse,133,0.18796992481203006,0.584
Chemical carcinogenesis - DNA adducts,84,0.16666666666666666,0.6
Gap junction,86,0.5930232558139535,0.63
Signaling pathways regulating pluripotency of stem cells,141,0.24822695035460993,0.644
Calcium signaling pathway,254,0.37401574803149606,0.671
Propanoate metabolism,34,0.47058823529411764,0.678
Sulfur metabolism,14,0.35714285714285715,0.691
Olfactory transduction,2230,0.002242152466367713,0.703
Pancreatic secretion,116,0.1810344827586207,0.704
Non-alcoholic fatty liver disease (NAFLD),151,0.5099337748344371,0.705
Sphingolipid metabolism,57,0.08771929824561403,0.719
Regulation of lipolysis in adipocytes,57,0.08771929824561403,0.739
Dorso-ventral axis formation,26,0.11538461538461539,0.755
Arachidonic acid metabolism,95,0.12631578947368421,0.759
Pancreatic cancer,76,0.6842105263157895,0.767
MicroRNAs in cancer,303,0.3432343234323432,0.771
Pyruvate metabolism,44,0.3181818181818182,0.776
beta-Alanine metabolism,37,0.13513513513513514,0.79
"Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA",6,1.0,0.807
Insulin signaling pathway,143,0.42657342657342656,0.809
Endocrine resistance,93,0.7204301075268817,0.817
Aldosterone synthesis and secretion,105,0.3333333333333333,0.821
Glycolysis / Gluconeogenesis,70,0.08571428571428572,0.824
Endocrine and other factor-regulated calcium reabsorption,61,0.16393442622950818,0.834
Diabetic cardiomyopathy,211,0.6872037914691943,0.84
African trypanosomiasis,39,0.07692307692307693,0.856
Arrhythmogenic right ventricular cardiomyopathy,77,0.2857142857142857,0.856
HTLV-I infection,283,0.6678445229681979,0.859
"Alanine, aspartate and glutamate metabolism",41,0.34146341463414637,0.879
Galactose metabolism,34,0.08823529411764706,0.884
Starch and sucrose metabolism,36,0.08333333333333333,0.885
Colorectal cancer,88,0.5795454545454546,0.885
Acute myeloid leukemia,70,0.4,0.891
Wnt signaling pathway,180,0.2777777777777778,0.893
Circadian rhythm,37,0.1891891891891892,0.898
Mineral absorption,56,0.125,0.911
cGMP-PKG signaling pathway,175,0.46285714285714286,0.912
Non-alcoholic fatty liver disease,156,0.5512820512820513,0.916
Cellular senescence,183,0.644808743169399,0.918
Biosynthesis of amino acids,84,0.17857142857142858,0.924
Mitophagy - animal,68,0.4411764705882353,0.933
Chemical carcinogenesis - reactive oxygen species,223,0.5067264573991032,0.945
Antifolate resistance,29,0.3103448275862069,0.946
Selenocompound metabolism,18,0.16666666666666666,0.949
FoxO signaling pathway,133,0.5789473684210527,0.95
Bile secretion,100,0.2,0.959
Pentose phosphate pathway,34,0.08823529411764706,0.964
Terpenoid backbone biosynthesis,24,0.125,0.965
Human T-cell leukemia virus 1 infection,249,0.7228915662650602,0.969
Arrhythmogenic right ventricular cardiomyopathy (ARVC),72,0.2916666666666667,0.989
Proximal tubule bicarbonate reclamation,22,0.13636363636363635,0.999
